Skip to main content

An Open-label Study of Ozanimod in Moderate to Severe Ulcerative Colitis in Clinical Practice

Terminated · Phase 4 · NCT05369832

Conditions: Colitis, Ulcerative

At a glance

Research payments reported, 2025
$1.5M
U.S. investigators named
68
Sites paid
54
Planned or actual enrollment
139

About the trial

Sponsor
Bristol-Myers Squibb
Tested
Ozanimod (drug)
Dates
Started 2022-12-16; completion 2025-04-11
Results posted
Yes

The purpose of this study is to explore the safety, efficacy, effects on quality of life (QOL), and biomarker response of ozanimod in participants with moderate to severely active ulcerative colitis (UC) in clinical practice.

From ClinicalTrials.gov, last updated 2026-02-10. Full record, eligibility and contacts (opens in a new tab)

Industry funding

E.r. Squibb & Sons, L.l.c. reported $1.5M in research payments for this study in 2025 (69 payments).

Products named: Zeposia

Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.

U.S. investigators named on this study

Clinicians the company named as principal investigators in its Open Payments reports.

Sites paid to run it

  • Texas Digestive Disease Consultants Southlake $283,368
  • Topography Health Inc $111,796
  • Gastroenterology Associates of Central Virginia $96,449
  • Weill Medical College of Cornell University $81,108
  • Houston Methodist Research Institute $65,314
  • Gastro Florida $61,858
  • Care Access Research Llc $59,788
  • Gi Center of the Mid Sout $49,013
  • Tyler Research Institute $48,167
  • Board of Regents of the University of Wisconsin Systems $45,434
  • University of Utah Hospital and Clinics, UT $41,153
  • Gastroenterology Research of San Antonio $37,364
  • Baylor Research Institute $34,604
  • Northwestern University School of Medicine $32,161
  • The Clinical Trials Network $31,670
  • University of Miami $28,231
  • Arizona Arthritis & Rheumatology Research, PLLC $26,521
  • NYU Langone Hospitals - Tisch Hospitals Clinical Labs $21,881
  • Cotton Oneil Cancer Center $20,913
  • Homestead Associates in Research, Inc $20,880
  • Gi Alliance Management Llc $19,407
  • Digestive Disease Medicine of Central New York, LLP $18,613
  • Swedish Medical Center, WA $18,069
  • Medical Associates Research Group, Inc $16,404
  • Novel Research Llc $14,711
  • Advanced Gastroenterology Associates, Llc $14,298
  • Om Research Llc $11,936
  • UC Health, University of Cincinnati $11,833
  • Gastroenterology Consultants, PC $11,800
  • Orlando Health, FL $11,590
  • Digestive Health Specialists of the Southeast $11,181
  • University of Louisville Research Foundation, Inc, $11,131
  • Boston Specialists $10,954
  • Kumc Research Institute, Incorporated $10,172
  • University of Arizona, Div of Sponsored Programs $9,854
  • Quality Medical Research, PLLC $9,726
  • Mngi Digestive Health $9,576
  • Southern Star Research Institute $9,481
  • Gastro One $9,286
  • Gi Pros $8,314
  • Clinical Applications Laboratories, Inc $7,100
  • Southern California Research $6,700
  • Biopharma Informatic Incorporated $6,563
  • Manhattan Clinical Research, Llc $5,805
  • Care Access Research $5,750
  • Tandem Allied Clinical Research Llc $5,604
  • St Charles Clinical Research Llc $5,250
  • Clinical Research Solution Llc $4,935
  • Alliance Medical Research Llc $4,500
  • University of Massachusetts School of Medicine $4,388
  • Gastroenterology Research of America Llc $3,634
  • Arkansas Gastroenterology PA $3,200
  • University of Massachusetts $3,185
  • Om Research, Llc $2,950

Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.